gimli
ACUTAAS stock analysis context
ACUTAAS CHEMICALS Stock Context for AI Screening
ACUTAAS CHEMICALS LIMITED is a small-cap stock in Healthcare. This page summarizes key screening signals for ACUTAAS CHEMICALS, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.
Ask Gimli about ACUTAASPrice
₹2,951.20
1M return
+21.79%
3M return
+40.10%
Market cap
₹24,161.81 cr
PE
93.04
ROE
+25.93%
RSI
68.27
Turnover
₹98.55 cr
Why it can matter in screens
- Momentum: ACUTAAS is above 50DMA, above 200DMA; RSI is 68.27.
- Returns: 1M +21.79%, 3M +40.10%, 6M +73.42%.
- Liquidity: latest turnover is ₹98.55 cr.
- Valuation: PE 93.04, PB n/a, ROE +25.93%, ROCE +31.51%.
- Growth: 3Y sales CAGR +24.34%, 3Y profit CAGR +30.17%.
Try these prompts
- Analyze ACUTAAS CHEMICALS with valuation, momentum and industry peers
- Compare ACUTAAS with other Healthcare stocks
- Show small-cap stocks in Healthcare above 50DMA with positive 1M return
- Find Healthcare stocks with improving momentum and reasonable valuation
Related screen ideas
- View Healthcare stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare ACUTAAS with other Healthcare stocks
Data snapshot: 2026-05-22. Not investment advice.